Testing effectiveness (Phase 2)Study completedNCT02206035
What this trial is testing
Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
Who this might be right for
Hematopoietic Stem Cell Transplantation
William R. Drobyski, MD 45